CALR and neoplasm: Silencing CD47 also downregulated MTT-based viability, whereas it significantly suppressed CALR-induced tumor inhibition in U2OS OS cells, TT2 OS cells, MDA-MB-231 breast cancer cells, and PANC1 pancreatic cells (Figure 5—figure supplement 4).